A/P 12.5/15 (Alogliptin Benzoate and Pioglitazone Hydrochloride 12.5 mg / 15 mg)
Pill with imprint A/P 12.5/15 is Yellow, Round and has been identified as Alogliptin Benzoate and Pioglitazone Hydrochloride 12.5 mg / 15 mg. It is supplied by Perrigo New York Inc..
Alogliptin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Alogliptin/pioglitazone 12.5 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for A/P 12.5/15
Alogliptin Benzoate and Pioglitazone Hydrochloride
- Imprint
- A/P 12.5/15
- Strength
- 12.5 mg / 15 mg
- Color
- Yellow
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Perrigo New York Inc.
- National Drug Code (NDC)
- 45802-0238
- Inactive Ingredients
-
mannitol, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, hypromellose 2910 (6 mPa.s), titanium dioxide, polyethylene glycol 8000, magnesium silicate, lactose monohydrate, ferric oxide yellow, ferric oxide red, carnauba wax, polyglyceryl-10 oleate, butyl alcohol, alcohol, shellac
Note: Inactive ingredients may vary.
Related Images for "A/P 12.5/15"
More about alogliptin / pioglitazone
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 2 Reviews
- Drug class: antidiabetic combinations
- FDA Alerts (5)
Consumer resources
Other brands: Oseni
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
